The trajectory of Viagra presents a challenging picture for those considering investment. While the initial launch generated massive profits, the expiration of its exclusive rights opened the door to cheaper competitors, dramatically eroding market share. This creates a particular dilemma for pharmaceutical companies depending on related blockbuste
Sildenafil and Pharma : A Uncertain Investment ?
The history of Viagra, and its developer click here copyright, presents a intriguing case study for investors. At first a blockbuster drug, generating billions in revenue , its intellectual property lapse created a deluge of generic competition , significantly impacting its dominance. While certain businesses may seek to capitalize on male sexual d